Dupixent for Atopic Dermatitis. Just Approved in
Post# of 72440
(Total Views: 350)
Posted On: 10/03/2018 2:01:41 PM
Dupixent for Atopic Dermatitis.
Just Approved in 2017.
$209mm sales for last qtr.
Almost clear to clear in 33% of patients.
Delivery Injection.
ADVERSE REACTIONS: The most common adverse reactions (incidence ≥1%) are injection site reactions, conjunctivitis, blepharitis, oral herpes, keratitis, eye pruritus, other herpes simplex virus infection, and dry eye.
Can't wait to see B in a cream for Atopic Dermatitis.
Looks like the bar for AD is set pretty low....
B is a freaking GOLD mine!
Just Approved in 2017.
$209mm sales for last qtr.
Almost clear to clear in 33% of patients.
Delivery Injection.
ADVERSE REACTIONS: The most common adverse reactions (incidence ≥1%) are injection site reactions, conjunctivitis, blepharitis, oral herpes, keratitis, eye pruritus, other herpes simplex virus infection, and dry eye.
Can't wait to see B in a cream for Atopic Dermatitis.
Looks like the bar for AD is set pretty low....
B is a freaking GOLD mine!
(7)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼